Correlation Between Insurance Australia and Lion Biotechnologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Insurance Australia and Lion Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Insurance Australia and Lion Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Insurance Australia Group and Lion Biotechnologies, you can compare the effects of market volatilities on Insurance Australia and Lion Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Insurance Australia with a short position of Lion Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Insurance Australia and Lion Biotechnologies.

Diversification Opportunities for Insurance Australia and Lion Biotechnologies

0.63
  Correlation Coefficient

Poor diversification

The 3 months correlation between Insurance and Lion is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Insurance Australia Group and Lion Biotechnologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lion Biotechnologies and Insurance Australia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Insurance Australia Group are associated (or correlated) with Lion Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lion Biotechnologies has no effect on the direction of Insurance Australia i.e., Insurance Australia and Lion Biotechnologies go up and down completely randomly.

Pair Corralation between Insurance Australia and Lion Biotechnologies

Assuming the 90 days horizon Insurance Australia Group is expected to generate 0.53 times more return on investment than Lion Biotechnologies. However, Insurance Australia Group is 1.9 times less risky than Lion Biotechnologies. It trades about -0.08 of its potential returns per unit of risk. Lion Biotechnologies is currently generating about -0.27 per unit of risk. If you would invest  492.00  in Insurance Australia Group on December 21, 2024 and sell it today you would lose (60.00) from holding Insurance Australia Group or give up 12.2% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Insurance Australia Group  vs.  Lion Biotechnologies

 Performance 
       Timeline  
Insurance Australia 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Insurance Australia Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.
Lion Biotechnologies 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Lion Biotechnologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Insurance Australia and Lion Biotechnologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Insurance Australia and Lion Biotechnologies

The main advantage of trading using opposite Insurance Australia and Lion Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Insurance Australia position performs unexpectedly, Lion Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lion Biotechnologies will offset losses from the drop in Lion Biotechnologies' long position.
The idea behind Insurance Australia Group and Lion Biotechnologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios